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Abstract 
Funding agencies and large public scientific institutions are increasingly using the term “research 
portfolio” as a means of characterising their research. While portfolios have long been used as a 
heuristic for managing corporate R&D (i.e., R&D aimed at gaining tangible economic benefits), they 
remain ill-defined in a science policy context where research is aimed at achieving societal outcomes. In 
this article we analyze the discursive uses of the term “research portfolio” and propose some general 
considerations for their application in science policy. We explore the use of the term in private R&D and 
related scholarly literature in existing science policy practices, and seek insight in relevant literature in 
science policy scholarship. While the financial analogy can in some instances be instructive, a simple 
transposition from the world of finance or of corporate R&D to public research is problematic. However, 
we do identify potentially fruitful uses of portfolio analysis in science policy. In particular, our review 
suggests that the concept of research portfolio can indeed be a useful analytical instrument for tackling 
complex societal challenges. Specifically, the strands of scholarship identified suggest that the use of 
research portfolio should: i) recognize the diversity of research lines relevant for a given societal 
challenge, given the uncertainty and ambiguity of research outcomes; ii) examine the relationships 
between research options of a portfolio and the expected societal outcomes; and iii) adopt a systemic 
perspective to research portfolios – i.e., examine a portfolio as a functional whole, rather than as the 
sum of the its parts. We argue that with these considerations, portfolio-driven approaches may foster 
social inclusion in science policy decisions, help deliberation between “alternative” portfolios to tackle 
complex societal challenges, as well as promote cost-effectiveness and transparency. 
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1. Introduction 
Tackling complex challenges – climate change, food security, poverty reduction, the risk of global 
pandemics – requires not only increased expenditure on targeted R&D, but also the exploration and 
eventual coordination of a variety of diverse research areas. Typically societal challenges benefit from 
the understanding of the physical and biological phenomena underlying a challenge (e.g. the virus and 
its genes), but also demand an understanding of the environmental and social contexts in which they 
occur, and the policy networks and instruments available in those contexts (Ely et al. 2014). Recent 
scholarship on so-called “grand challenges” has also highlighted a need to find alternative models for 
funding research, administering it and connecting it to policy outcomes (Swedish Presidency of the 
European Union 2009; Reid et al. 2010; Mowery 2012). Recent examples include the European Joint 
Programming initiatives1, which aim to tackle pressing societal issues through alignment of funding and 
increased collaboration across EU countries, or the research and operational funding from the Bill and 
Melinda Gates foundation2
Science policy funding schemes for complex societal problems or grand challenges seek to better align 
science supply with social problems or needs. 
. However, it is unclear whether research efforts such as these are successful 
in promoting closer alignment between the stated goals or expected societal contributions and the 
actual outcomes, despite new rhetoric or increased stakeholder engagement. 
3
For the sake of clarity, let us begin by proposing a definition of “research portfolio”, to be used just as a 
reference while we review of the different practices and understandings associated with the term. We 
understand a “research portfolio” as the ensemble or subset of research activities supported by a 
funding agency, a large research performing organisation or a given subset of agencies/organisations.  It 
is a heuristic and analytical tool for an organisation to contrast its missions against its de facto priority 
setting as illuminated by the portfolio analysis, i.e. the areas in which it is putting effort, investments or 
achieving some outcomes. In medical research, it is common to think of portfolios in terms of 
therapeutic areas as research options, which can then be aligned with disease burdens or market 
demands (Agarwal and Searls, p. 2009, p. 868). Here we propose a different approach: to explore the 
activities of agencies and organisations for a given grand challenge (hence a subset of their overall 
activity), as a means to reflect on the research options that are being supported (and think as well about 
those that are lacking support).  
 To do so, they have to answer the question that lies at 
the “neglected heart of science policy” (Sarewitz and Pielke 2007): how should resources be distributed 
across various research areas (science supply) so that they address societal needs (social demand)? In 
this article, we investigate the notion of research portfolio in the context of public, problem-oriented 
research and we explore how this concept may be helpful as an analytical tool to help address grand 
challenges.  
                                                          
1 http://ec.europa.eu/research/era/joint-programming-initiatives_en.html 
2 http://www.grandchallenges.org/Pages/Default.aspx  
3 Following Hicks (2014), we define grand challenges as multifaceted, multidisciplinary, large-scale and policy 
oriented problems with both an intellectual and practical component. 
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To put it in a simple image, a research portfolio is like the palette of colours of painters, with colours 
representing research areas, as illustrated in science visualisations.4
Since the assessment of research options is inevitably influenced by subjective judgements about what 
are the appropriate solutions for a given problem or need, accounting for research investment in purely 
monetary terms is neither possible (because of huge uncertainties in the type of “impact”) or desirable 
(because it avoids societal deliberation on the values of research outcomes), as exemplified by 
challenges faced in recent attempts to quantify the returns on health research (Buxton et al. 2008). The 
inappropriateness of purely monetary measures has lead scholars and policymakers to inquire as to 
other measures of “value” of public research, namely in terms of desired societal outcomes (Bozeman 
and Sarewitz 2005; Cozzens and Snoeck 2010; Fisher et al. 2010; Bozeman and Sarewitz 2011; Foray et 
al. 2012). In this context, the notion of research portfolios is becoming increasingly popular as funders 
and performers of research strive not only to “maximize” the “performance” of individual research 
projects, but also to somehow consider the aggregate “performance” of a given set of projects in terms 
of their contribution to diverse ultimate objectives, often of some societal relevance.   
 A portfolio analysis tells the analyst 
about the distribution of research options sustained. This conceptualisation of research portfolio is 
analogous to that developed for energy portfolios, in which different technologies (options) can be 
deployed to fulfill a societal need, in this case energy production (Awerbuch 2006; Stirling 2007; Bazilian 
and Roque 2008). 
The purpose of the paper is to explore how the notion of research portfolio could be used as a heuristic 
for fostering deliberation in science, primarily to reflect on research priorities and project selection in 
the face of a limited capacity to steer research in the short or medium terms in public organisations. We 
build on recent progress in exploring concepts such as research portfolio in the context of public 
research management (Srivastava et al. 2007; Dietz and Rogers 2012). But while previous research had 
discussed governmental research portfolios by combining qualitative and quantitative methods and 
examining both output-based and “human capital”-based portfolios (Bozeman and Rogers 2001), our 
focus is concerned with portfolios oriented towards explicit societal problems, such as climate change or 
obesity. 
The article first reviews the literature on research portfolios and related science policy contributions. 
Second, it suggests some general principles on the basis of the reviews. Through a review of the 
literature within the public and private sectors, we find that methods applied to analyse  private-sector 
R&D portfolios, though relatively well-developed, cannot simply be transposed to public science policy. 
A more holistic and multi-dimensional approach is required. The increased popularity of “research 
portfolio” in the public reflects a variety of issues beyond funding and evaluation: from accountability to 
skills to economic outputs. However, the notion is currently underdeveloped and generally used in an 
overly-simplified fashion by public-sector research organizations. The same can be said regarding its 
increased use in the scholarly literature, highlighting a gap in science policy discourse, despite the 
                                                          
4 See for example, the illustration of (research) portfolios in terms of funding in the recent work of UberResearch. 
(http://www.uberresearch.com/visual-portfolios/) or in terms of publications in Rafols, Porter and Leydesdorff 
(2010) (http://www.idr.gatech.edu/maps). 
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availability of theories and methodologies which could be applicable to public-sector research portfolios. 
Our review of other relevant science policy literature, on the other hand, points to the possibility of a 
fruitful research agenda for developing a portfolio-based approach to tackle a given complex, 
multidisciplinary societal challenge. In particular, existing literature points to the need for recognizing 
the inherent uncertainty in the outcomes and research options, focusing on the alignment of research 
with societal outcomes, and examining research portfolios from a systems perspective. We conclude by 
discussing some possible implications of this approach, not only in terms of achieving global societal 
objectives, but also in terms of developing more efficient, transparent and inclusive science policy. 
2. The conceptual assumptions behind research portfolios 
Dietz and Rogers (2012) have recently shown the usefulness of re-examining the use of concepts (or 
buzzwords that contain them) such as “transformative research”, which are polysemous and ambiguous 
yet often taken for granted in science policy discourse. Distinct analogies and metaphors are thus 
revealed. The effects (alleged “successes” or “failures”) of putting such concepts in policy practice 
depend in part on a consistent understanding of what they entail. To examine how research portfolios 
are thought of and applied in public and private sector contexts we will, in the subsequent sections, 
analyze the conceptual “baggage” that various uses of the term research portfolio implicitly carry. In the 
present section, we provide some general justification for why this is necessary.. 
Metaphors and analogies are fundamental in developing new knowledge, be it in the context of new 
theories, applications or entire fields of research (Kuhn 1979; Freeman 1991). Similarly, analogies can 
play a central role in developing narratives which underpin decision-making, namely in the policy realm 
(Schwenk 1988). Here, we are concerned with the use of the term “portfolio” as a metaphor borrowed 
from the world of corporate management. This is an instance of a “conceptual metaphor” (Lakoff & 
Johnson, 1980): a concept which colours the way we think about phenomena, and help us make sense 
of them within the context of a given field of study – in this case, science policy. Indeed, just as much of 
the basis of neoclassical economics lies in metaphors borrowed from the physical sciences (Mirowski 
1991; Bernard Cohen 1993), analogies from the field of economics permeate the natural sciences 
(Ghiselin 1978; Hammerstein and Hagen 2005) From a related perspective, the search for increased 
quantification – which often points to econometric or finance-based approaches – permeates many 
areas of the social sciences and of public policy (Porter, 1995). While analogies are an important source 
of creativity and a means to interpret and explain observed phenomena, we will show the need to move 
beyond a simple analogy of portfolios in finance or in private sector R&D towards more solid 
foundations for the management of public science. 
Part of the difficulty with using the portfolio as an instrument for policy lies in the vagueness of the term 
itself, and thus its propensity to be interpreted based on existing analogous usages. A portfolio, taken on 
its own, might conjure up a collection of art projects, the responsibilities of a minister or, more likely, a 
set of investments. At a most basic level, a research portfolio refers a collection of research activities 
under a single umbrella, generally a funder, performer or an entire country, but each of these activities 
may have been conceived for a variety of reasons. In general the portfolio is an outcome of research 
activities rather than pre-conceived strategy. This contrasts with a research program in which the 
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projects, or other activities, are part of the same directed endeavour with some specific pre-conceived 
timeframe and objectives. We do not set any a priori restrictions on types of research or fields that can 
be usefully explored with portfolio analysis, nor on the degree to which portfolios have been explicitly 
designed in a top-down manner (e.g., one can look at the portfolio of a specific research programs). 
Indeed, one can conceive of portfolios within any single discipline or within the context of purely “blue-
sky” research, e.g. as a means of exploring the disciplinary diversity within a fundamental research 
organisation such as the European Molecular Biology Organisation (Rafols, Porter and Leydesdorff, 
2010). In these cases, the interest of the portfolio is to understand the relative balance between 
research areas or approaches. However, we believe that portfolios can be particularly helpful tools on 
problem-oriented research such as health, agriculture or in complex societal challenges like climate 
change, because the portfolio may help illuminate and discuss hitherto hidden cognitive lock-in and 
biases that favour certain technological solutions over others (Sarewitz, 1996; Stirling and Scoones, 
2009). The usefulness of portfolio analysis for mission-oriented research is also suggested by the fact 
that funding organisations such as the NIH or the Wellcome Trust are among the first to use it in science 
policy. 
To provide a sense of the scope of usage in the literature, Figure 1 shows the increase in publications 
with the term “research portfolio” (or related terms5
                                                          
5 Documents were downloaded from the Web of Knowledge in May 2014. The search was limited to original 
articles, reviews and editorial material, and to any of the following search strings and their plural forms: “research 
portfolio”, “science portfolio", “research and development portfolio”, “R&D portfolio”, “scientific portfolio”, 
“portfolio of research”, “portfolio of R&D”. 
) within the English-language academic literature 
(covered by Web of Knowledge), which is dominated by titles such as Research Technology 
Management, IEEE Transactions on Engineering Management, European Journal of Operational 
Research, Research Policy and Research Evaluation. The increase is significantly greater than the overall 
rate of growth of publications found in the database (dashed line in Figure 1). As shown in Figure 2, an 
examination of the publications on portfolios reveals that there are three categories of articles and 
reviews according to a clustering algorithm (Waltman et al. 2009) that finds topics focused on 
biomedical research (top right), on science policy in general (bottom right) and on industrial research 
(left), which is the focus of this section. The size of the circles represents the number of occurrences 
(with the smallest circles representing 10 occurrences, for clarity), while the closeness between two 
given terms is a two-dimensional representation of the frequency of co-occurrences (i.e., the 
“relatedness”) of the terms.  These categorizations, in particular the distinction between health and 
science policy-oriented scholarship on the one hand, and innovation policy on the other hand, are 
supported out by a co-citation analysis of sources (not shown here) using the same software and data 
from the Web of Knowledge. Discussions of the management of private-sector R&D reveal more 
technical and in-depth discourse than discussions of public-sector R&D, where “research portfolios” are 
more often used  to describe a phenomenon in practice (e.g., NSF spending), without associated 
theories or methodologies.  
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Figure 1: Main graph: Number of publications related to research portfolios in titles, keywords and abstracts in scientific 
literature (Web of Knowledge). Inset: Data expressed as a ratio of total number of documents present in the Web of 
Knowledge database (approx. 2.2M in 2013), to show that the increase is not an artefact due to overall database size6
 
. 
Figure 2. Map created from the co-occurrence network of terms found in scholarly articles on "research portfolios" in the 
Web of Science for the period, using the software VOSViewer. The red cluster (left side) corresponds largely to the literature 
on management of private-sector R&D, the green cluster (top right side) corresponds to biomedical research portfolios, 
while the blue cluster (bottom right) corresponds to broader science policy issues, with a focus on health.  
 
                                                          
6 Data retrieved June 2014 from http://wokinfo.com/ 
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In the following four sections, we review the practice and the scholarly contributions on research 
portfolios. We observe both reports of substantial practice (section 3) and scholarly work (section 4) on 
private R&D portfolios, increasing usage of the term research portfolio in science policy practice (section 
5), but a relatively few and only recent explicitly scholarly contributions on the topic from a science 
policy perspective. In section 6 we review insights from science policy research which we believe are 
directly relevant to public portfolios. Table 1 below summarizes the main findings, highlighting the gap 
in the bottom-right quadrant which we address in the section 6. 
Table 1. Roadmap of this review of existing practices and literature (sections 3 to 6).7
 
 
Research policy practices Scholarly contributions 
Private R&D focus 
Section 3 
• Using harmonized firm-wide 
management practices for R&D 
• Applying portfolio management 
tools to R&D 
Section 4 
• Methods for ranking R&D projects 
(risk and return) 
• Measurement of correlations 
between projects 
• Quantitative tools (e.g., models) to 
support decision-making 
Public R&D focus 
Section 5 
• Focusing on improved accountability 
and management practices 
• Using tools and skill-sets for 
planning, managing and reporting 
on research 
• Using newly available data and new 
data analytics 
Section 6 
• Studies of technological risk and 
uncertainty 
Potential insights to fill existing gaps: 
• Priority-setting in STI policy  
• Evaluation of societal outcomes 
• Public-value mapping 
• Research as a “complex system” 
 
3. Research portfolio practices in the private sector 
Somewhere between the financial analogy and how science policy scholars view public-sector research 
lies the treatment of corporate R&D. In the context of a manager seeking to maximize returns on 
investment, it may seem that it makes economic sense to approach R&D programs with a portfolio 
analysis, given the very high uncertainty in the success rate of individual projects. Considering each 
individual R&D project separately presents serious risks for the overall success of an R&D program, given 
the uncertainties in the associated chances of success and potential economic returns. Just as firms have 
often sought to integrate R&D within a broader product development cycle, managing the “R&D 
department” has meant adopting a birds-eye view of the entire set of research operations. In industrial 
                                                          
7 We thank Tommaso Ciarli for suggesting to include this table as a means to organize and summarize much of the 
reviewed information. 
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R&D, one can also think of the origins of using portfolios as being simply a means to score or rank R&D 
projects (Souder and Mandakovic 1986).  
Managing R&D has certainly evolved to be quite distinct from financial management, but the basic 
philosophies are analogous. In fact, while the quintessential “portfolio” approach to managing financial 
products is not considered straightforward (Altman and Saunders 1998), especially given the rise of new 
types of options pricing methods, efforts to use the approach for maximizing the return on research 
investment have continued to grow in popularity and complexity, while encountering little criticism. The 
rhetoric of optimization of investments, in various forms, has remained dominant in firms conducting 
R&D either as part of or the bulk of their operations (Devinney and Stewart 1988). One of the clearest 
illustrations of this point lies in the management of patents, which mirrors and informs the management 
of R&D at various stages along the commercialization spectrum. Patent portfolios can be explicitly 
viewed through strategic lenses for long-term firm growth, guarding against market-based risk, and 
focusing on the diversity of patents in order to gain a competitive edge, considering patents as 
equivalent to financial assets (Ernst 1998). A big research question is to which extent management 
practices follow the rhetoric of profit maximisation or instead are dominated by more strategic or 
political drivers.  
Since one cannot draw a dividing line between public sector and private sector research management 
practices, the idea of R&D portfolio management has leaked into public science. Strong linkages 
between universities and private industry were already important in the development of science (and 
science policy) in the post-war years. The rise of new public management in the public sector over the 
past thirty years has sought to increase alignment with private sector practices (Georghiou 1998), and as 
a consequence, the administration of public research has been strongly influenced by the management 
of private sector R&D. But translation from corporate to public management is not always appropriate 
or insightful, particularly when we are speaking of research in support of complex societal challenges. In 
addition, efforts at managing public research according to private sector principles often fail to 
recognize the dominant (and diverse) organizational and disciplinary contexts. 
4. Scholarly work on corporate R&D portfolios 
R&D portfolios as a tool for decision-making in private-sector R&D have been extensively analysed in the 
academic literature, often in journals associated with management studies or engineering. Emerging in 
the post-war years, the literature on how to manage many R&D projects within a firm has been growing 
since the 1960s, and in particular between the late 1980s and the 2000s. This body of work not only has 
an impact on the overall literature, but also on public sector administration, which is often informed by 
private sector approaches to management (Eikenberry and Drapal Kluver 2004).  
For private sector institutions conducting relatively large amounts of R&D, the aggregate level of 
analysis provided by a portfolio approach is critical in terms of identifying interdependencies among 
projects, namely in view of minimizing risk and maximizing financial return. In 2002, Chen-Fu Chien laid 
out a portfolio-based framework for selecting R&D projects by first summarizing existing portfolio 
selection processes (Chien 2002). The approaches and principles that he describes as guiding how 
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companies maximize returns and minimize risk are not new: Chien describes how previous efforts have 
led to incremental methodological improvements to help organizations make decisions about projects 
not on the basis of their individual merit, but on their collective value. Another of Chien’s significant 
contributions was to articulate a general process governing R&D portfolio selection, based primarily on 
the definition of portfolio objectives, on the selection of a scale which is appropriate for linking 
attributes (or measurements) of the entire portfolio with individual projects, and on making 
comparisons with alternative portfolios. The basic idea is to link project measurements and portfolio 
measurements with the consideration of project interrelation. In other words, a portfolio analysis should 
consider co-variance, seeking first to understand the interdependencies between projects, second trying 
to optimise the portfolio outcome that reflects the positive and negative effects of interdependencies 
on the performance, and third, comparing synergistic portfolio attributes such as diversity. Minimizing 
risk is central to all explicit treatments of corporate R&D portfolios we have examined and 
diversification is key to dealing with situations of high risk. While risk is simplified as the variance on 
return in purely financial approaches (Markowitz 1952), it can also refer to various  concerns for R&D 
firms, related to uncertainty in market returns or to the inherent possibility of failure of a given 
technology, for example (Luo 2011).  
Since overall portfolio risk is depends on how the projects are connected to each other, different 
strategies for diversification can be employed to mitigate risk (Bekkum et al. 2009).Given strong 
organisational pressures to avoid perceptions of failure, if portfolios are analysed at an individual project 
level, there is the danger that social learning is inhibited. Such a risk can be mitigated if portfolio 
management is carried at the level of the whole portfolio, as discussed in detail in section 6.3. 
On this basis, various forms of “real option”-based strategies (i.e., decisions related to tangible elements 
of R&D projects) have been developed and are advocated to guide investment in R&D (e.g., Vonortas 
and Desai 2007), though even this is not straightforward to transport from the world of finance to R&D 
management (Perlitz et al. 1999). The underlying assumption in the R&D portfolios literature is that 
portfolio analysis would allow for more “rational” or “evidence-based” decisions regarding the 
composition or size of a portfolio in order to optimize return. Mathematical treatments purportedly 
allow one to better reach such an optimal composition or, at the very least, provide a range of options 
that can facilitate decisions. Various multi-criteria decision-making tools have thus been developed to 
analyze and, to some degree, interpret data pertaining to R&D projects (Linton et al. 2002). For example, 
one can envisage a multi-stage quantitative process for developing a portfolio which seeks to ensure 
that the projects selected are of high quality and are well aligned with a decision-maker’s explicit 
priorities (Stummer and Heidenberger 2003). 
But while monetary return dominates the way financial (and other) portfolios are constructed, one can 
envisage a set of guiding allocation principles, which can set risk tolerance, as well as extend to national 
capacity building or sustainable development criteria for example. Furthermore, different time horizons 
can be considered, which dramatically change how choices of projects or financial instruments are 
made. Nevertheless, the overarching concern of managers (and shareholders) of firms is to ensure the 
long-term and short-term viability of the program or organization.  
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Comparisons and analogies from the financial world have been instructive in suggesting features of a 
research portfolio, in particular related to interactions and risk. For instance, one can build a 
microeconomic theory which posits distinct “competition” dynamics from a standard market model 
(Dasgupta and Maskin 2012). However, if we broaden the objectives of the portfolio analysis to a range 
of “public good” outcomes, we must move away from a straightforward transposition of such 
approaches since a high “rate of return” and low risk can no longer be viewed as dominant objectives, as 
we will discuss in the sections that follow. 
5. Portfolio-related practices in public research management 
Like other fields of public management/administration or public policy, science policy is associated with 
a set of tools and approaches that supports and guides the organizational processes of public 
institutions. In this section, we explore the diversity of existing practices related to or research 
portfolios. This review is based on a “desk analysis” of scholarly work and policy documents and is thus 
of limited empirical robustness – an ethnographic study would be needed to confirm whether this 
discourse on portfolios is a fair representation of actual practices. Broadly, these practices often fall 
under the umbrellas of delivering individual public science-based programs, or of more “horizontal” 
functions such as planning and reporting on activities, or managing financial and human resources. But 
they represent disparate interpretations and, in many cases, the term “portfolio” is used in ambiguous 
or superfluous ways, in comparison with R&D project management.  
The term “research portfolio” has in part become more frequently used due to the increased availability 
of (and ability to mine) data, possibly also due to the desire to use tools from other disciplines – namely 
economics – to examine science policy (Marburger 2005; Srivastava et al. 2007). The development of 
systems such as the US NIH Research Portfolio Online Reporting Tools (RePORT) or the UK Gateway to 
Research illustrates this trend towards public availability of portfolio-relevant data.8
First, portfolios are increasingly used to provide an overview of a set of projects or programs through an 
ex post review process. Organizations such as the Wellcome Trust have also begun carrying out portfolio 
analyses to see their funding on specific major health issues such as malaria as a means to take stock of 
existing research and explore future paths (Dolby et al. 2012). This is one of the few cases where the 
focus is on a set of identifiable societal outcomes; in general, portfolio reviews are focused on 
organizational priorities or measures of “research quality”. In such instances, the portfolio being 
examined can be theme or program-specific, such as a recent review of human research at NASA 
(National Research Council 2012), or consist of a heterogeneous set of research projects conducted by a 
 Particularly in the 
context of health research, this data has led science policy consultants such as RAND corporation to 
start thinking about new ways of assessing projects for funding purposes (Ismail et al. 2010; Guthrie et 
al. 2013). We can distinguish three main activities in which "portfolio" approaches are said to be used: 1) 
as the “bird’s eye view” of the activities of an agency or organisation, 2) as the set of skills needed by 
research managers, or 3) as  
                                                          
8 See http://report.nih.gov and http://gtr.rcuk.ac.uk 
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large unit, for example, at the scale of a university (Portfolio Review Group 2014), or perhaps even that 
of an entire country (National Science Board 2001). 
Within the NIH, there have been several discussions of research portfolios in recent years – the term has 
been useful in beginning to frame inputs and outputs of research. The NIH has thus begun to use 
portfolios as a means to perform “strategic” reviews, but more importantly, as a tool for publically 
accounting for expenditures and understanding research outputs or outcomes. The NIH RePORT has also 
led to an increased ability of scholars to critically review specific research portfolios and make 
meaningful comparisons (Boyack and Jordan 2011; Meador et al. 2011). Specifically, individual institutes 
or topics (e.g., Alzheimer’s research) are increasingly being thought of as portfolios of investments or 
projects which, together, constitute the budget of the organization. New computational algorithms and 
scientometric methods for clustering research areas and classifying scientific documents (grants, 
publications or patents) can help in constructing relevant units of analysis for various research outputs 
(Waltman and van Eck 2012; Skupin et al. 2013; Kay et al. 2014)9
Second, many public and private-sector organizations have begun a daily management of their research 
funds or operations that is, at least rhetorically, a “portfolio” approach. Here, we cannot associate the 
term with a particular methodology, but rather a management skill-set, which we contend is also 
borrowed from “portfolio managers” in the financial sector and focusing on “nimble” alignment with 
organizational imperatives, the capacity to manage and prioritise multiple projects, and an 
understanding of risk-management.
. Yet, there is still no agreement on how 
a public research portfolio is defined or how it should be analyzed. 
10
“[The] Translational Research Manager [position]… will play an important role in 
ensuring that fundamental research is translated into new therapies and diagnostics, … 
working with [scientists and clinicians] to develop a credible development plan and 
successful applications for funding. The post holder will provide advice on suitable public 
funding schemes (e.g. MRC, Wellcome Trust), support the development and submission 
of grant applications, and provide project management support to successfully funded 
programmes.”
 One can also view this in terms of a part of the trend towards the 
standardization of management practices across the both public and private sector. This also implies a 
shift in the focus of research portfolios from the organizational or societal objectives to the performance 
of the individual manager and the projects under his or her supervision (Golec 1996). This is illustrated 
through one of many job advertisements by research funding and performing agencies:  
11
 
 
                                                          
9 There is even a new company, ÜberResearch (http://www.uberresearch.com/) specialised in the analysis of 
research portfolios of funding agencies. 
10 For example, see a typical description of such skills at: http://www.pmi.org/Professional-Development/Career-
Central/Three-Must-Have-Skills-for-Portfolio-Managers.aspx (accessed June 20, 2014).  
11 Excerpts from a recent job vacancy posting at the National Health Service (italics added). 
http://jobs.gstt.nhs.uk/job/UK/London/London/Guys_St_Thomas_NHS_Foundation_Trust/Biomedical_Research_C
entre/Biomedical_Research_Centre-v318965 (accessed June 20, 2014) 
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Beyond anecdotal evidence, we can illustrate this diversity of discourse on the term “research portfolio” 
within the public sector through an exploratory “web-scraping” technique, whereby we extract the 
content from web-pages and parse it into a format which can be analyzed. Recent development of such 
techniques has showed promise in social sciences research (Marres and Weltevrede 2013). In this case, 
we search for the most relevant results of “research portfolios” in Google.com, restricted to domains 
often, but not exclusively, associated with the public sector12. Applying an identical mapping procedure 
as in Figure 2 with scientific abstracts13 provides us with a sense of the breadth of contexts where 
“research portfolios” are mentioned as shown in Figure 3 (here we don't perform clustering since we are 
artificially selecting distinct sources through our web search). Figure 3 supports the insights of our 
manual cursory analysis14
  
 of these contexts, which are primarily related to: professional profiles and job 
offers, profiles of research organizations, strategic planning documents (including evaluations), and 
investment profiles. Separate high-density areas (i.e., high-occurrence of the term, in dark/red colour in 
the figures) are found around common terms such as “university” or “report”, indicative of distinct 
contexts for research portfolios. As is found from the scholarly literature (see Figure 2, above), the 
health sector remains most prevalent among web results, which are associated primarily with 
universities, government institutes and private companies. However, the most important conclusion to 
draw from this exploratory exercise is that although the term is broadly used in public and private 
science policy contexts, it is so far used without semantic specificity. 
                                                          
12 We perform a Google search for “research portfolios” from websites ending in: .eu, .ca, .uk, .au, and .gov, then 
extract the context of each “research portfolio” result using the Outwit software package. Finally, we perform a 
manual cleaning, removing spurious and duplicate results, which leaves us with 1186 distinct search contexts.  
13 Here, we keep all the relevant terms extracted, removing only “research” and “research portfolio” as terms 
which are common to the bulk of the results. 
14 Complementing the mapping approach, we perform a manual analysis of the results by looking for how often 
some of the most common strings occur. These strings are mainly related to employment (“job”, “vacancy”, etc.), 
planning and reporting (“accountability”, “outcome”, etc.), financial return (“investment”, “fund”, etc.), and 
general descriptions (“overview”, “profile”, etc.). 
13 
 
 
Figure 3: Density map obtained from co-occurrence of terms contained through "research portfolio" web search. Note the 
variety of contexts, from employment to innovation, as well as the diverse sectors: health (bottom right), universities 
(center/bottom left), government (center), and industry (top right). Red (darker) represents higher density and the font size 
is proportional to the number of occurrences of a term. 
 
Overall, as a depiction of both an organization’s activities or of a management skill-set, portfolios are 
often used as a rhetorical device that suggests some (actual or desired) managerial “improvement”. 
Invoking portfolio analysis appeals not only to a more rigorous management of (public or private) 
research, but also points to a more in-depth, evidence-based or holistic view of research programmes. 
For instance, some of the earlier uses of the term “research portfolio” has been used to argue for basic 
defense-sponsored research (Wulf 1998) among other debates regarding the federal research budget, 
pertaining not only to funding levels but coordination issues (Sponberg 2005). In general, the appeal to 
the notion of a research portfolio is made in relation to mission-oriented research, for example, aging or 
agricultural research (Robertson et al. 2008; Liggins et al. 2010). However, it is also be used to bring 
together disparate types of research under the same umbrella, such as in the case of all national 
defense-funded basic research, or “high-risk” (in terms of potential malevolent misuse) research 
activities (Kuehn 2012). Finally, it may also refer to detailed discussions of methods for evaluating a set 
of research projects within specific contexts such as that of the NIH (Haak et al. 2012). 
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The concept of research portfolios also aligns well with more managerial science policy goals of cost-
effectiveness, accountability and transparency. Indeed, recent years have seen greater effort to account 
for public funds spent on R&D. Initiatives such as Science of Science Policy and STAR Metrics led by U.S. 
science policy and science funding organizations are prime examples of a worldwide trend of trying to 
show and assess the contributions of research to society (Holbrook and Frodeman 2011; Largent and 
Lane 2012). This search for greater transparency and accountability is being developed by means of 
better data on social and economic benefits of research, but is also related to improving the way funds 
are allocated and their use is evaluated. 
In most cases discussed in this section, exactly what defines a portfolio or how it is to be designed, 
managed or assessed are issues not explored in detail. Rather, the term tends to be used to suggest to a 
more efficient or holistic approach. Nevertheless, these developments underscore the fact that there is 
a demand for such a concept in policy circles.  
6. Towards an appropriate use of portfolio analysis in science policy  
After reviewing the very limited conceptual and methodological robustness of current portfolio analyses 
in practice, one may wonder whether portfolio analysis can be a useful tool in science policy. To answer 
this question in this section,we reviewed the scholarly contributions broadly related to research 
portfolios. Although there has been some science policy scholarship which specifically deals with the 
question (Bozeman and Rogers 2001; Sarewitz and Pielke 2007), most of the literature is not explicitly 
related to portfolios. We find that portfolio analysis can indeed be a useful instrument in science policy, 
but that an appropriate use requires some important general considerations. First, the recognition of 
the uncertainty and ambiguity of what are desirable outcomes of a portfolio. Second, the need to 
critically analyse the alignment between research options with expected outcomes. Third, the 
importance of taking a holistic view of the portfolio, i.e. of analysing synergistic dynamics and 
considering outcomes of the portfolio ensemble rather than its parts. Each consideration is discussed in 
a subsection below. 
6.1 Beyond the financial metaphor: from risk and returns to uncertainty and 
ambiguity in outcomes 
A potential approach in public research portfolios would be to further develop the financial analogy 
used in private R&D portfolios (as reviewed in sections 3 and 4). In recent years, there have been many 
complex computational models explored to enable decisions on public portfolios (pertaining to research 
or other endeavours), given a set of explicit social preferences on the part of the decision-maker 
(Fernandez et al. 2013). However, these leave no room for diverging perspectives or for qualitative 
valuations of societal goals. Our contention is that, as it stands, the financial analogy cannot be applied 
to portfolios of public science whose primary objective is to achieve various types of public good 
outcomes; we must turn to new approaches. Similarly, tools and approaches developed for private-
sector R&D cannot simply be transferred to public policies because they are not developed to work with 
multiple desirable outcomes. 
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One reason why the use of the financial metaphor in research portfolios is problematic is illustrated by 
work by Andy Stirling and colleagues on risk analysis and knowledge mapping (Stirling and Scoones 
2009), as shown in Figure 4. In the financial metaphor it is essential to have precise estimates of the 
degree of risk (e.g. volatility) and returns (benefits of a given research outcome). This means developing 
metrics which assume that the knowledge of the type of outcomes and the knowledge of the likelihood 
of those outcomes are unproblematic (top left in Figure 4).  
However in the case of public good research, making assumptions about the outcomes and likelihoods is 
extremely problematic. For example, the desired outcomes of research in virology might be the 
development of an antiviral drug or a vaccine, or perhaps improvements in diagnostics, but an 
unintended outcome might be an infection to the population via unintended release of a virus, for 
example. These various intended or unintended societal outcomes each have a very uncertain degree of 
likelihood (vertical axis in Figure 4) and different people will value them differently (labelled as 
“ambiguity”  in Figure 4) which is why they cannot be simply added up into one dimension (this is 
analogous to concerns over methodologies in general, as found in Moravcsik 1984). As a result, the 
expected social return cannot be computed as a “return”—rather than risk-based expectations (top left 
corner in Figure 4), in the case of research portfolios we have both uncertainty and ambiguity, a 
situation of highly incomplete knowledge,  close to ignorance. This is particularly true as the outcomes 
are further into the future, which could, for example require more exploratory research. How we treat 
uncertainty also depends on how well defined the specific challenge is, and to what degree a specific 
body of knowledge to address it already exists.  
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Figure 4: Schematic representation of contrasting states of incomplete knowledge (adapted from Stirling & Scoones, 2009) 
Under conditions of highly incomplete knowledge, there is a need to consider multiple potentially 
valuable outcomes and multiple research options as pathways to each outcome. Hence there are two 
rationales for diversification: 1) in the vertical axis (from top to bottom) diversifying research options as 
a means to hedge against the uncertainty that a specific research options achieve the desired outcomes; 
2) in the horizontal axis (from left to right) diversifying research options so that various outcomes are 
pursued, given that different actors have contrasting views on the relative value of outcomes. Drawing 
from the same example as above, there are different technical paths to developing effective vaccines to 
guard against deadly epidemics, but there are also many different outcomes (new vaccines, improved 
hygiene, new surveillance techniques) which can help mitigate this uncertainty --and each of them 
requires technical paths somewhat different from those needed by vaccines. These are two points that 
have been very salient in energy portfolios given the high volatility of energy prices (uncertainty) and 
controversies over the use of some technologies (e.g. in nuclear plants) (ambiguity). Work by Shimon 
Awerbuch describes how, under these conditions, in “dynamic and uncertain environments, the relative 
value of [energy] generating technologies must be determined not by evaluating alternative [energy] 
resources, but by evaluating alternative resource portfolios.” (Awerbuch, 2006, p. 693; see also Bazilian 
& Roque, 2008) 
Considerations of diversity should also include capacity-building objectives, as well as requirements for 
duplication (as a means to build in mechanisms for replication or to explore slightly different pathways) 
within a given portfolio and among different portfolios. In addition, high levels of specialization (and 
thus low diversity) for a given organisation in a certain field or sub-field may present perceived 
advantages for increasing levels of collaboration and developing transferable techniques or 
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technologies. Moreover, if one were to consider a set of several research portfolios from different public 
institutions, where all would benefit from progress (either incremental or transformative) in a given 
area, then once again diversification for one organisation may not always be beneficial for the aggregate 
portfolio (Dasgupta and Maskin 2012).  
6.2 Alignment of research options with outcomes 
That science is conducted in conditions of incomplete knowledge does not mean that the analyst cannot 
make decisions based on informed guesses about the relation between research and social impact: it is 
well documented that certain research options are much better aligned to certain outcomes (Sarewitz 
1996, 31–49). A trivial example might be that research on mosquitoes is more likely than research on 
asteroids to be relevant to malaria. Historically, several lines of inquiry in science policy have explored 
the alignment between research options and outcomes, namely related to priority-setting and 
evaluation of research, but also to broader considerations related to the “supply” and “demand” of 
policy-relevant science. In order to deepen our understanding on the issue of alignment, here we review 
three research strand: 1) priority-setting in funding; 2) evaluation of socio-economic outcomes of 
research, including public value-mapping, 
First, while priority-setting (i.e., choosing scientific fields or approaches) is distinct from our focus on 
constructing a portfolio for a given problem, it raises many of the same questions. The debate over how 
priorities of research are decided dates back to postwar science management. In 1963, Alvin Weinberg 
famously posed the question of how to decide between what types of science to perform, citing 
scientific, technological and societal factors, with the latter dimension being the most problematic 
(Weinberg 1963).  Weinberg tentatively posits some criteria – such as the transdisciplinary relevance of 
a given field – for assessing the societal benefits of a field of research. Once again, spurred on in part by 
the growth of what was perceived as “Big Science”, Michael Moravcsik (1988) took up the same debate 
two decades later, arguing for the importance of assessing scientific fields according not only to internal 
(disciplinary) criteria, but also to broader social impacts and relevance to the scientific community. 
Similarly, on a national scale, one can envisage a set of criteria which could enable the comparison of 
alternate research programmes – or portfolios – based on “social needs” (Snellen 1983). These debates 
highlight the importance of considering scientific work beyond narrow disciplinary boundaries and in 
terms of broader societal outcomes, namely through inclusion of a broader range of factors and 
stakeholders (Brooks 1978). A specific instance of priority-setting in the literature has dealt with health 
research, in particular examining which diseases are and should be the target from large research 
efforts, based on public health demands or a measured “burden” of diseases (Agarwal and Searls 2009, 
867–869; Røttingen et al. 2013; Evans et al. 2014). 
This literature acknowledges that priority-setting is essentially political. In the 1990s, following the end 
of the cold war, public science in the United States and elsewhere saw an increased push for new goals, 
for setting priorities and allocating funds (McGeary and Smith 1996). At the very least, scientists and 
science managers became increasingly aware of the need to compete for funds with other public 
programs, for example after the cancellation of the US Superconducting Supercollider (Sarewitz, 1996, 
pp. 1-4). In the field of health research, for example, patient groups, doctors and the private sector 
engage in dialogue while having diverging views and interests on priorities for research (R. Smith 1988). 
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Indeed, many funding organizations engage in extensive consultations to determine some of these 
priorities. But little is currently said or done about the implementation of these (generally high-level) 
priorities through research portfolio analysis. Priority setting has been argued to be especially important 
when there are shrinking or flat budgets (as it the case now) since one can argue that incremental 
changes from year to year do not allow to adapt investment to changing environments such as new 
societal problems or emergence of scientific fields. This highlights the need for so-called “risky” research 
with potentially high payoffs (which is not well served by peer review selection, as suggested by 
Nicholson and Ioannidis, 2012), as well as for making potentially painful judgments across fields  
(McGeary and Smith 1996).  
Second, there is a wealth of literature pertaining to evaluation of public science according to societal 
needs or demand, which discusses the desirability of including a broader social and economic context in 
research evaluation. In particular, scholars focused on ex post evaluation have made strides in capturing 
some of the societal outcomes associated with research, but this continues to be both very difficult and 
controversial (Cozzens 1997; Salter and Martin 2001; Martin 2011). This difficulty, as well as a paucity of 
data, may partially explain why many over-simplified indicators and methods of evaluation continue to 
dominate evaluations in the public sector. Today, intrinsic surrogate measures of “scientific quality” 
(such as journal impact factor or citations) remain central to measuring research in support of societal 
outcomes, despite a willingness of managers and policymakers to include a greater variety of evaluation 
methods and indicators (Feller 2012; Scientific Management Review Board 2013).  
More specifically, and setting aside for a moment the obvious lack of quantitative data, the attribution 
of changes in the social or economic spheres to research projects, or even areas, is often extremely 
problematic (European Commission 2005; Cozzens and Snoeck 2010). Nevertheless, in the health 
sciences, substantive efforts have been made to explicitly capture public policy outcomes of scientific 
research (Hanney 2003; Boaz et al. 2008). New interpretations of standard quantitative indicators on 
outputs (e.g., from bibliometric data) (Hanney et al. 2005) and new frameworks, such as that of 
productive interactions (Molas-Gallart and Tang 2011; Spaapen and van Drooge 2011), have proven 
useful in gaining insight into the impacts of scientific research on social spheres, such as industry or 
policy. However, in the case of ex ante evaluation there is still a lack of tools for mapping potential 
socially-beneficial outcomes to research programs, as demonstrated by the challenges in expanding the 
role of peer review processes to focus on relevance or alignment (Holbrook and Frodeman 2011; 
Frodeman and Briggle 2012). 
The idea of pragmatically applying “public values” to the evaluation of research has developed in recent 
years thanks in part to the work of Daniel Sarewitz and Barry Bozeman (Bozeman and Sarewitz 2005; 
Bozeman and Sarewitz 2011) who move away from strictly economic thinking about societal outcomes 
of science. Their treatment of public research extends a justification for public investment in science 
beyond what is simply considered a “market failure”. Their understanding the public values and societal 
outcomes associated with specific areas of science could be part of a toolkit of methodologies for 
research portfolios analysis and for assessing the relative value of “alternative” portfolios that to move 
beyond the status quo. 
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Bringing public values to the forefront in portfolios not only poses the challenge of moving beyond a 
dominant economic model of thinking about the science policy process, but also that of identifying 
criteria for success or failure in either public or private research in addressing these public values. The 
co-existence of divergent criteria puts the focus on some mechanisms of societal deliberation as part of 
the portfolio-building process which includes as a first step identifying what values are articulated by 
stakeholders. This implies seeking or eliciting a plurality of views which may often not be explicit in 
public discourse. The onus is thus on the policymakers to identify the values being considered, to 
identify where public and private failures exist and ensure that the public values persist at the forefront 
of a given science policy process. Finally, at the heart of the deliberation is the fact that the priorities of 
scientists, science managers and potential social demands rarely align.  
To foster alignment it is necessary to better understand the current state of the science (the supply) and 
what is required to achieve social goals (the demand) (Garfinkel et al. 2006; Sarewitz and Pielke 2007). 
The “demand” side must consider not only the plurality of outcomes, but also various ways of 
articulating specific science- or technology-driven pathways for achieving them. Similarly, the “supply” 
side is not just about how much “high-risk, high-return” research should be undertaken, but also about 
what type of outcomes are somewhat likely (in spite of high uncertainty) to result from a given line of 
research.  
By putting the emphasis on the outcomes and on their connection to research enterprise, a portfolio 
analysis helps bridge the gap between the supply and demand. The former implies public and 
stakeholder engagement in shaping a research portfolio, revealing the values and expectations and 
attempting to connect them to potential research avenues. The latter implies considering how the social 
and institutional mechanisms affect the links between allocated resources and outcomes (Laudel and 
Gläser 2014). More broadly, understanding these micro-mechanisms (which is a big challenge!) would 
allow connect governance and research content, namely via the actions of researchers in responding to 
and in influencing science policy decisions (Gläser 2012). Identifying the explicit expectations of 
stakeholders becomes paramount for portfolio analysis in the case of societal challenges. For example, 
organizational or national  imperatives related to capacity development mean that in specific instances 
research portfolios should be described in terms of learning and capabilities rather than research 
outputs (Bozeman and Rogers 2001).  
In summary, in this subsection we have argued that portfolio analysis for public research should 
consider the alignment between supply and demand -- and found that there is a substantial and growing 
literature on priority setting and socio-economic benefits of research that can be mobilised for exploring 
this alignment. 
6.3 A systemic, whole portfolio-level approach 
The preceding two sub-sections, as well as our examination of the dominant existing practices (both 
drawn from corporate R&D analogies and from current public research imperatives), point to the need 
to tackling research portfolios in a systemic manner. By a systemic approach we mean that the portfolio 
should analysed as a whole, taking into account interactions and synergistic properties of the research 
options. Specifically, this means that the values or performances investigated in a research portfolio 
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should not only be the sum of the individual performances of research options. Instead, portfolio 
performances should include interactions and synergies between research options, as widely as 
thoroughly discussed in the literature (Chien 2002, 364–365; Stirling 2007, 712–714).15
Quantitative and qualitative approaches have been developed for assessing how scientific and non-
scientific programs are performing “as a whole”, beyond the mere sum of individual projects (Ruegg 
2007; Srivastava et al. 2007). Ex ante evaluation has thus benefitted from new methods which can 
examine entire fields such as energy R&D (National Research Council 2005). More generally, recent 
years have seen significant developments in the construction of frameworks for performance indicators 
that take into the dynamics of entire sectors as well as a broader set of potential socio-economic 
impacts (Jordan et al. 2008). However, despite efforts in this direction and calls for change within the 
scholarly literature (Arnold 2004), the assessment of interactions has little formalisation – in contrast, 
for example, to economic studies such as the “product space” formalism in the context of export/import 
goods (Hausmann et al. 2013). 
 In sum, the idea 
is that the analysis should be carried out to the portfolio as a whole, and that analysis should compare 
whole portfolios between them rather than research options. This approach means to carry out the 
management of portfolio at the whole portfolio-level. 
At the heart of portfolio analysis lies the expectation that one should seek support for positive 
interaction between research projects or areas. While straightforward numerical optimization algorithms 
are difficult to envisage in the context of complex and multi-faceted socio-economic outcomes, 
advances in data availability and improved understanding of research as a “complex system” can lead to 
useful heuristics (K. Smith 2000). The characterization of research avenues in disciplinary terms, specific 
methods, as well as their institutional or social settings, can help decision makers conceive of linkages 
between projects. Similarly, potential or planned interactions between projects can also be identified 
through the narratives associated with them and through the underlying objectives that purport to drive 
the work.  
Research portfolio analyses may help to explicitly value and recognize social, institutional and cognitive 
complementarity and synergy, which in turn can lead to new means of coordination or new 
collaborations, for example. In the health sciences, in particular, this is in line with efforts to foster 
translational research, i.e., bringing together clinical and basic research (Woolf 2008). More generally, 
policy instruments that encourage collaborations and the flow of information are key to fostering 
interactions within portfolios, including learning derived from failures. The complexity of linkages across 
areas (for which measures exist) can be associated with richness of the underlying knowledge 
capabilities, which in turn, can be associated with the capacity of a country or an organisation to solve 
problems or to create prosperity, when viewed from a social or economic perspective (Hausmann et al. 
2013). 
One means of seeking out these positive interactions is through trying to understand the structure and 
dynamics of the topic-based research landscape, which we define as the ensemble of original scientific 
                                                          
15 To avoid confusion, let us stress that this definition of system is purely functional and, in principle, unrelated to 
the literature of national, regional or technological innovation systems. 
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work underway on a given topic. It can be based on data related to funding and publications, and/or 
from consultations with a range of experts. And it can be viewed through a lens of cognitive, social and 
institutional proximity, in the context of the overall breadth of global science. In particular, by showing 
cognitive proximity, global maps of science offer provide a sense of the range of existing theories and 
methodologies with a connection to a given set of outcomes, which is conducive to identifying potential 
gaps and positive interactions (Rafols et al. 2010). However, these type of global (either disciplinary or 
journal-based) maps are likely to prove of limited usefulness in many specific problems in which 
research options are topic specific rather than disciplinary (Wallace & Rafols, manuscript in preparation). 
Since portfolio analysis is most meaningful at scales where one can envisage – and measure – positive 
interactions between elements, the entire set of research projects of large country, for example, may be 
more challenging to consider (although one can certainly talk about priority-setting). Conversely, when 
operating at the level of a few projects, or a larger number of projects which focus on a very narrow line 
of research, a portfolio analysis (as we describe it here) may have little added value as the criteria for 
decisions become scientific nature and can be directly judged by peers (Weinberg 1963, 164–165). Thus 
the “meso-level” of analysis which has been advocated for evaluation (Hage et al. 2007; Jordan et al. 
2008) and which is also particularly useful for capturing social impact (Molas-Gallart and Tang 2011), 
may also be the most useful scale for portfolio analysis and design. Such a scale could be broad enough 
to capture the “realm of possibilities” as a means to generate new ideas for alternative portfolios, and 
to allow for thinking about wider governance issues (legal, institutional, policy and cultural aspects of a 
socio-technical regime) which empower or constrain such alternatives (Geels 2004). 
In summary, this subsection has argued that portfolio analysis is most appropriate at a systemic, whole-
portfolio level, in particular using the notion of a topic-based research landscape as a heuristic and 
operating at a “meso-scale”, which allows interactions among portfolio elements to become visible or 
measurable. 
7. Conclusion 
This article has explored the concept and use of research portfolio analysis as a tool for management in 
science policy. We have traced several applications and uses (at highly varying degrees of rigor and 
sophistication). We found that the basic financial metaphor and corporate R&D approach is inadequate 
for public policy and that its current, wide-ranging uses in science policy are sometimes can be useful in 
some instances, but are too often ambiguous and rarely refer to specific tools or concepts. Instead we 
propose three considerations for carrying our portfolio analysis, namely: i) recognising uncertainty and 
ambiguity in the research areas and outcomes; ii) fostering the alignment between research supply and 
demand; iii) carrying out a systemic, whole-portfolio level analysis. This approach namely implies that 
one-dimensional and reductionist characterizations of portfolios in terms of risk and return must be 
replaced with portfolio analyses that consider multiple options and plural outcomes. 
We view this study as a first step towards developing more concrete policy design and implementation 
recommendations. Applying portfolios as an analytical tool has implications for how some of the societal 
problems of public research—climate change, poverty reduction, global diseases, etc.—are addressed. 
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For example, the portfolio analysis also provides an opportunity for moving beyond a simple dichotomy 
of “applied” vs. “basic” research, blurring the already poorly-defined distinction between the two 
(Calvert 2006) and focusing instead on the diversity of approaches and methodologies aligned with 
expected or desired outcomes.  
Greater emphasis on portfolios can favour a more balanced approach to managing public research, 
which is currently dominated by a push for “excellence”, despite the fact that this term is itself 
problematic (Rafols et al. 2012; Stilgoe 2014). We have proposed a move away from a unidimensional 
view of a portfolio focused on a single “performance” measure (be it in terms of “scientific quality” or 
financial return). Similarly, this might also imply a move away from an over-reliance of evaluation on the 
current peer-review system, which also tends to focus on a narrow, field-specific view of excellence. The 
dominance of peer-review has recently been called into question, not only in terms of the burden it can 
entail (particularly if it is to be the only means to assess a project), but also in the context of a lack of a 
transparency and a tendency to force conformity among applicants (Ioannidis 2011; Nicholson and 
Ioannidis 2012; Chalmers et al. 2014), not to mention contributing to high levels of false findings or 
“wasted resources” (Ioannidis 2014). Portfolio analysis, on the other hand, could help in diversifying 
rather than promoting homogeneity, namely by actively exploring a range of alternative portfolios and 
explicitly considering levels of diversity. Portfolio analysis  can also favour a shift towards a management 
of public science with a greater focus on interdependencies between projects or research areas 
(including a focus on standardization, collaboration, data sharing, etc.) than is currently the norm.  
The focus on societal challenges in this paper is driven by our perception that the logics of a public 
portfolio analysis are particularly well suited foster societal benefits related to a given goal or more 
generally for mission-oriented research. One can also apply a research portfolio analysis to large public 
research organisation or university. In this case, the portfolio logic still may apply in terms of the 
socioeconomic missions of the organisations and in terms of promoting accountability and transparency, 
and thinking strategically about balance of research options. 
Efforts to develop research portfolios for the public sector, beyond the dominant “financial” analogy, 
could help allocate funding to better align science with underlying societal outcomes and public values, 
improve integration and foster new synergies, while promoting a more transparent science policy 
process. As research portfolios are becoming increasingly used in policy, in this article we have 
attempted to “unpack” and “untangle” the use of the term “research portfolio”. By clarifying some of 
the assumptions underlying this term and by pointing to potential paths forward for practice and 
scholarship, we hope to advance debate and dialogue among (and between) scholars and policy-makers 
so that science can become more successful in helping address societal needs.  
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